Overview

Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the preventive effect of stroke between triflusal and clopidogrel in ischemic stroke patient based on the cytochrome P450 2C19 (CYP2C19) polymorphism.
Phase:
Phase 4
Details
Lead Sponsor:
Gangnam Severance Hospital
Collaborators:
Myung In Pharmaceutical Company
Yonsei University
Treatments:
Clopidogrel
Salicylates
Ticlopidine
Triflusal